Please provide your email address to receive an email when new articles are posted on . 38% of patients with cutaneous lupus erythematosus displayed evidence of positive interferon (IFN)-alpha ...
Are there studies of pegylated interferon alfa and ribavirin for the treatment of patients with type 1a hepatitis C virus infection? Additional studies are clearly needed. Still, because of overall ...
Chemotherapy As an Alternative to Radiotherapy in the Treatment of Stage IIA and IIB Testicular Seminoma: A Spanish Germ Cell Cancer Group Study Bevacizumab plus IFN produces a superior PFS and ORR in ...
Brii Biosciences Limited ("Brii Bio," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical ...
Feb. 13, 2004 — Interferon-alpha-2B (IFN-alpha-2B) injected into the plaque may improve the symptoms associated with Peyronie's disease, according to the results of a study published in the January ...
Ropeginterferon alfa-2b — a next generation, mono-pegylated interferon alfa-2b isoform — administered once every 2 weeks demonstrated safety and efficacy in patients with polycythemia vera, according ...
The COMBI study, a prospective, open‐label, single‐arm phase 2 study ongoing in Denmark, is investigating the feasibility of treating patients with low- to intermediate-risk myelofibrosis ...
DALLAS – Nov. 16, 2001– Researchers at UT Southwestern Medical Center at Dallas and the Baylor Institute for Immunology Research in Dallas have linked abnormal secretion of alpha interferon to the ...
A chemically modified (pegylated*) form of interferon alfa-2b improves recurrence-free survival (RFS) in melanoma patients compared with observation alone, conclude authors of an Article in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback